161 related articles for article (PubMed ID: 10705557)
1. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use.
Stuer-Lauridsen F; Birkved M; Hansen LP; Lützhøft HC; Halling-Sørensen B
Chemosphere; 2000 Apr; 40(7):783-93. PubMed ID: 10705557
[TBL] [Abstract][Full Text] [Related]
2. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals.
Jones OA; Voulvoulis N; Lester JN
Water Res; 2002 Dec; 36(20):5013-22. PubMed ID: 12448549
[TBL] [Abstract][Full Text] [Related]
3. Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?
Ferrari B; Mons R; Vollat B; Fraysse B; Paxéus N; Lo Giudice R; Pollio A; Garric J
Environ Toxicol Chem; 2004 May; 23(5):1344-54. PubMed ID: 15180389
[TBL] [Abstract][Full Text] [Related]
4. Environmental risk assessment of selected pharmaceuticals in Turkey.
Oğuz M; Mihçiokur H
Environ Toxicol Pharmacol; 2014 Jul; 38(1):79-83. PubMed ID: 24929476
[TBL] [Abstract][Full Text] [Related]
5. Risk screening of pharmaceutical compounds in Romanian aquatic environment.
Gheorghe S; Petre J; Lucaciu I; Stoica C; Nita-Lazar M
Environ Monit Assess; 2016 Jun; 188(6):379. PubMed ID: 27234514
[TBL] [Abstract][Full Text] [Related]
6. Environmental risk assessment of musk ketone and musk xylene in The Netherlands in accordance with the EU-TGD.
Tas JW; Balk F; Ford RA; van de Plassche EJ
Chemosphere; 1997 Dec; 35(12):2973-3002. PubMed ID: 9415982
[TBL] [Abstract][Full Text] [Related]
7. Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface Waters.
Straub JO; Oldenkamp R; Pfister T; Häner A
Environ Toxicol Chem; 2019 Oct; 38(10):2259-2278. PubMed ID: 31225916
[TBL] [Abstract][Full Text] [Related]
8. Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges.
Christensen AM; Markussen B; Baun A; Halling-Sørensen B
Chemosphere; 2009 Oct; 77(3):351-8. PubMed ID: 19682723
[TBL] [Abstract][Full Text] [Related]
9. Initial ecological risk assessment of eight selected human pharmaceuticals in Japan.
Yamamoto H; Nakamura Y; Nakamura Y; Kitani C; Imari T; Sekizawa J; Takao Y; Yamashita N; Hirai N; Oda S; Tatarazako N
Environ Sci; 2007; 14(4):177-93. PubMed ID: 17762841
[TBL] [Abstract][Full Text] [Related]
10. A rational approach to selecting and ranking some pharmaceuticals of concern for the aquatic environment and their relative importance compared with other chemicals.
Donnachie RL; Johnson AC; Sumpter JP
Environ Toxicol Chem; 2016 Apr; 35(4):1021-7. PubMed ID: 26184376
[TBL] [Abstract][Full Text] [Related]
11. Exposure simulation for pharmaceuticals in European surface waters with GREAT-ER.
Schowanek D; Webb S
Toxicol Lett; 2002 May; 131(1-2):39-50. PubMed ID: 11988357
[TBL] [Abstract][Full Text] [Related]
12. Ecotoxicological risk assessment of chosen pharmaceuticals detected in surface waters.
Załęska-Radziwiłł M; Affek K; Doskocz N
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2017 Nov; 52(13):1233-1239. PubMed ID: 28949837
[TBL] [Abstract][Full Text] [Related]
13. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001.
Straub JO
Toxicol Lett; 2002 Oct; 135(3):231-7. PubMed ID: 12270681
[TBL] [Abstract][Full Text] [Related]
14. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001.
Straub JO
Toxicol Lett; 2002 May; 131(1-2):137-43. PubMed ID: 11988366
[TBL] [Abstract][Full Text] [Related]
15. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment.
Cunningham VL; Binks SP; Olson MJ
Regul Toxicol Pharmacol; 2009 Feb; 53(1):39-45. PubMed ID: 19013494
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Prioritisation Schemes for Human Pharmaceuticals in the Aquatic Environment.
Letsinger S; Kay P
Environ Sci Pollut Res Int; 2019 Feb; 26(4):3479-3491. PubMed ID: 30515684
[TBL] [Abstract][Full Text] [Related]
17. Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs?
Coetsier CM; Spinelli S; Lin L; Roig B; Touraud E
Environ Int; 2009 Jul; 35(5):787-92. PubMed ID: 19201471
[TBL] [Abstract][Full Text] [Related]
18. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline.
Grung M; Källqvist T; Sakshaug S; Skurtveit S; Thomas KV
Ecotoxicol Environ Saf; 2008 Oct; 71(2):328-40. PubMed ID: 18068226
[TBL] [Abstract][Full Text] [Related]
19. Environmental risk assessment of metformin and its transformation product guanylurea: II. Occurrence in surface waters of Europe and the United States and derivation of predicted no-effect concentrations.
Caldwell DJ; D'Aco V; Davidson T; Kappler K; Murray-Smith RJ; Owen SF; Robinson PF; Simon-Hettich B; Straub JO; Tell J
Chemosphere; 2019 Feb; 216():855-865. PubMed ID: 30385066
[TBL] [Abstract][Full Text] [Related]
20. Occurrence and preliminarily environmental risk assessment of selected pharmaceuticals in the urban rivers, China.
Zhou H; Ying T; Wang X; Liu J
Sci Rep; 2016 Oct; 6():34928. PubMed ID: 27713558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
